Bottom line
EDIV vs XLV: the short answer
EDIV (State Street(R) SPDR(R) S&P Emerging Markets Dividend ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
XLV is cheaper at 0.08% vs 0.49% — a difference of $41 a year per $10,000 invested.
Over five years, EDIV returned +11.7% a year vs +8.1% for XLV.
Updated Nov 19, 2026
EDIV vs XLV side by side
| EDIV | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | SPDR (State Street) |
| Category | Dividend & Equity Income | Health Care Sector |
| Expense ratio | 0.49% | 0.08% |
| Annual cost per $10k | $49 | $8 |
| 10-yr cost on $10k (prospectus) | $616 | $103 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | +16.0% | +14.5% |
| 5-yr return (annualized) | +11.7% | +8.1% |
| 10-yr return (annualized) | +9.4% | +9.8% |
| Best quarter | +15.6% | +14.5% |
| Worst quarter | −29.8% | −12.7% |
| Net assets (fund) | $1.2B | $40.6B |
| Number of holdings | 112 | 65 |
| Portfolio turnover | 9% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | EDIV | XLV | Difference |
|---|---|---|---|
| 2025 | +16.0% | +14.5% | +1.5% |
| 2024 | +13.2% | +2.5% | +10.7% |
| 2023 | +41.0% | +2.0% | +39.0% |
| 2022 | −15.4% | −2.1% | −13.4% |
| 2021 | +10.9% | +25.9% | −15.0% |
| 2020 | −9.1% | +13.3% | −22.4% |
| 2019 | +11.4% | +20.7% | −9.3% |
| 2018 | −6.4% | +6.3% | −12.7% |
| 2017 | +28.0% | +21.7% | +6.3% |
| 2016 | +16.7% | −2.8% | +19.6% |
Source: Fund prospectus bar charts
Holdings overlap
EDIV and XLV share none of their top holdings.
EDIV top 10
- Sino-American Silicon Products Inc — 3.49%
- Ambev SA — 3.44%
- Sinbon Electronics Co Ltd — 2.62%
- Banco Bradesco SA — 2.21%
- Saudi Telecom Co — 2.07%
- NEPI Rockcastle NV — 2.00%
- State Street Global Advisors — 1.97%
- Arca Continental SAB de CV — 1.90%
- Nedbank Group Ltd — 1.89%
- Abu Dhabi National Oil Co for Distribution PJSC — 1.86%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between EDIV and XLV?
EDIV (State Street(R) SPDR(R) S&P Emerging Markets Dividend ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs. XLV is cheaper at 0.08% vs 0.49% — a difference of $41 a year per $10,000 invested.
Which is cheaper, EDIV or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both EDIV and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.